near Gothenburg. This now looks odds-on to be shut down if Pfizer secures the takeover bid in the next few weeks. Many US commentators are predicting closure of Pfizer and AstraZeneca research ...

HEADQUARTERS IN ROCKVILLE. THIS LAB ISN’T OPEN OR OPERATIONAL YET, BUT ONCE IT IS, THE FOLKS AT ASTRAZENECA BELIEVE IT IS GOING TO REVOLUTIONIZE CANCER TREATMENT. IT GIVES US HOPE. I MEAN.

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. AstraZeneca on Tuesday confirmed it has closed down its neuroscience research group to direct resources ...

May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...

EPS: US$1.88 (up from US$1.41 in 1Q 2024). We've discovered 2 warning signs about AstraZeneca. View them for free. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded ...

New Delhi: UK pharma major AstraZeneca in partnership with health-tech company Qure.ai, announced the completion of 5 million artificial intelligence (AI) enabled chest X-rays (CXRs) across more ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of annual sales of $3 billion to $5 billion for the 3-in-1 inhaler.

KALOS and LOGOS included approximately 4,400 randomized patients. Also Read: Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis The trials met all ...

AstraZeneca’s share price has fallen a long way this year, which could mean a bargain to be had, so I ran the key numbers to check if this is the case. When investing, your capital is at risk ...

AstraZeneca disclosed another potential fine in China. Ono unveiled layoffs in a notice filed in Massachusetts. And more. Akeso’s initial overall survival data for its Summit Therapeutics ...